Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults
Joon Young Song, Hye Won Jeong, Jong Woo Yun, Jacob Lee, Heung Jeong Woo, Joon‐Yong Bae, Man‐Seong Park, Won Suk Choi, Dae Won Park, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim
Topics & Concepts
MedicineAdverse effectSeroconversionHantaan virusVaccinationImmunogenicityBooster doseImmunologyClinical trialInternal medicineAntibodyImmunizationVirusHantavirusViral Infections and VectorsViral Infections and Outbreaks ResearchVector-Borne Animal Diseases